-
Date: February 09, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Monoclonal gammopathies (MGs) comprise a broad set of diseases involving the abnormal clonal proliferation of plasma c...
-
Date: January 31, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Immunohistochemistry (IHC) is a standard technique for scientists and pathologists to detect antigens. Examining one o...
-
Date: January 19, 2023 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CET) There has been an evolution of organized HPV screening programs from the pap smear to liquid-based cytology, which has...
-
Date: January 17, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) As SARS-CoV-2 infections continue to ebb and flow, other respiratory viruses have made a big comeback on the world stag...
-
Date: December 14, 2022 Time: 12:00pm (PST), 3:00pm (EST), 9:00pm (CET) Adopting novel technologies is essential for improving patient outcomes, but the key to sustainable success is through...
-
Date: December 08, 2022 Time: 12:00pm (PST), 3:00pm (EST), 9:00pm (CET) Register for our upcoming webinar “Accelerate your IVD assay development with the unique support of the Dynabead...
-
Date: November 30, 2022 Time: 12:00pm (PST), 3:00pm (EST), 9:00pm (CET) Prior to 2022, monkeypox virus was a rare cause of disease in humans with most cases being associated with travel to t...
-
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
-
Date: November 16, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Autoantibody assays may have significant differences due to the heterogeneity of autoantibodies, including epitope spe...
-
In this webinar, Dr. Becky Winslow, infectious disease clinical scientist, details urinary tract infections’ incidence and impacts; the standard urine culture’s (SUC) technical c...
Globally, in 2020, 38 million people were living with HIV with an additional 1.5 million newly infected. During this period, 73% of those living with HIV were accessing antiretroviral therap...